Grail, Inc. (GRAL) Insider Trading
Insiders sold $38.1M and bought nothing on the open market.
27% of the selling was scheduled in advance under 10b5-1 plans. Chief Executive Officer Robert P Ragusa sold $6.17M on Apr 8, 19% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.
Get an email when GRAL's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15 | Joshua J. Ofman Chief Executive Officer | Sold10b5-1 plan 6 parts | 20,000 | $136.85 average | $2.74M | 5.5% | Form 4 |
| Oct 5 | Andrew John Partridge Chief Growth Officer | SoldNo plan | 7,873 | $146.39 | $1.15M | 4.8% | Form 4 |
| Oct 5 | Aaron Freidin Chief Financial Officer | SoldNo plan | 23,619 | $146.39 | $3.46M | 9.5% | Form 4 |
| Sep 21 | Aaron Freidin Chief Financial Officer | Sold10b5-1 plan 3 parts | 4,100 | $93.34 average | $383k | 1.6% | Form 4 |
| Sep 21 | Joshua J. Ofman Chief Executive Officer | Sold10b5-1 plan 8 parts | 61,452 | $97.74 average | $6.01M | 15% | Form 4 |
| Aug 27 | Joshua J. Ofman Chief Executive Officer | Sold10b5-1 plan | 5,000 | $85.02 | $425k | 1.2% | Form 4 |
| Aug 27 | Aaron Freidin Chief Financial Officer | Sold10b5-1 plan | 7,900 | $85.01 | $672k | 3.0% | Form 4 |
| Jun 4 | Andrew John Partridge Chief Growth Officer | SoldNo plan | 1,491 | $61.08 | $91k | 0.9% | Form 4 |
| Apr 8 | Aaron Freidin Chief Financial Officer | SoldNo plan | 45,806 | $49.92 | $2.29M | 15% | Form 4 |
| Apr 8 | Robert P Ragusa Chief Executive Officer | SoldNo plan | 123,502 | $49.92 | $6.17M | 19% | Form 4 |
| Apr 8 | Joshua J. Ofman President | SoldNo plan | 61,665 | $49.92 | $3.08M | 14% | Form 4 |
| Mar 5 – 9 | Aaron Freidin Chief Financial Officer | SoldNo plan 3 parts | 3,147 | $48.96 average | $154k | 1.0% | Form 4 |
| Mar 5 – 9 | Joshua J. Ofman President | SoldNo plan 3 parts | 3,627 | $48.86 average | $177k | 0.8% | Form 4 |
| Mar 5 – 9 | Robert P Ragusa Chief Executive Officer | SoldNo plan 3 parts | 8,441 | $48.48 average | $409k | 1.3% | Form 4 |
| Mar 2 | Joshua J. Ofman President | SoldNo plan 2 parts | 17,002 | $50.17 average | $853k | 3.7% | Form 4 |
| Mar 2 | Aaron Freidin Chief Financial Officer | SoldNo plan 2 parts | 9,573 | $50.17 average | $480k | 3.0% | Form 4 |
| Mar 2 | Robert P Ragusa Chief Executive Officer | SoldNo plan 2 parts | 37,504 | $50.17 average | $1.88M | 5.5% | Form 4 |
| Dec 3, 2025 | Joshua J. Ofman President | SoldNo plan | 13,000 | $100.00 | $1.3M | 3.4% | Form 4 |
| Dec 3, 2025 | Robert P Ragusa Chief Executive Officer | SoldNo plan 4 parts | 40,000 | $95.24 average | $3.81M | 5.5% | Form 4 |
| Dec 3, 2025 | Aaron Freidin Chief Financial Officer | SoldNo plan | 25,000 | $99.15 | $2.48M | 8.8% | Form 4 |
| Nov 17, 2025 | Aaron Freidin Chief Financial Officer | SoldNo plan | 1,697 | $79.20 | $134k | 0.6% | Form 4 |
| Nov 17, 2025 | Illumina, Inc. Large holder | SoldNo plan | 1,000,000 | $79.85 | $79.8M | 22% | Form 4 |
| Oct 15, 2025 – Oct 16, 2025 | Joshua J. Ofman President | Sold10b5-1 plan 2 parts | 14,979 | $78.47 average | $1.18M | 3.8% | Form 4 |
| Oct 15, 2025 | Robert P Ragusa Chief Executive Officer | SoldNo plan | 7,239 | $68.88 | $499k | 1.0% | Form 4 |
| Oct 6, 2025 | Joshua J. Ofman President | SoldNo plan | 81,385 | $62.50 | $5.09M | 17% | Form 4 |
| Oct 2, 2025 | Joshua J. Ofman President | Sold10b5-1 plan | 9,692 | $64.00 | $620k | 2.0% | Form 4 |
| Aug 19, 2025 | Joshua J. Ofman President | SoldNo plan | 4,202 | $32.02 | $135k | 0.9% | Form 4 |
| Aug 19, 2025 | Aaron Freidin Chief Financial Officer | SoldNo plan | 877 | $32.02 | $28k | 0.3% | Form 4 |
| Jul 15, 2025 | Aaron Freidin Chief Financial Officer | Sold10b5-1 plan | 8,000 | $38.93 | $311k | 2.7% | Form 4 |
| Jul 1, 2025 | Chun R Ding Large holder | SoldNo plan 3 parts | 339,800 | $49.53 average | $16.8M | 9.3% | Form 4 |
| Jun 30, 2025 | Joshua J. Ofman President | Sold10b5-1 plan | 9,692 | $52.00 | $504k | 1.9% | Form 4 |
| Jun 12, 2025 | Joshua J. Ofman President | Sold10b5-1 plan | 9,692 | $42.30 | $410k | 1.9% | Form 4 |
| May 2, 2025 | Joshua J. Ofman President | SoldNo plan | 48,213 | $33.93 | $1.64M | 8.6% | Form 4 |
| May 2, 2025 | Aaron Freidin Chief Financial Officer | SoldNo plan | 41,150 | $33.93 | $1.4M | 12% | Form 4 |
| May 2, 2025 | Robert P Ragusa Chief Executive Officer | SoldNo plan | 94,035 | $33.93 | $3.19M | 11% | Form 4 |
| Mar 11, 2025 | Aaron Freidin Chief Financial Officer | SoldNo plan | 1,816 | $31.20 | $57k | 0.5% | Form 4 |
| Mar 11, 2025 | Robert P Ragusa Chief Executive Officer | SoldNo plan | 7,625 | $31.21 | $238k | 0.9% | Form 4 |
| Mar 11, 2025 | Joshua J. Ofman President | SoldNo plan | 2,109 | $31.20 | $66k | 0.4% | Form 4 |
| Mar 7, 2025 | Robert P Ragusa Chief Executive Officer | SoldNo plan | 7,625 | $31.21 | $238k | 0.9% | Form 4 |
| Mar 7, 2025 | Joshua J. Ofman President | SoldNo plan | 2,109 | $31.20 | $66k | 0.4% | Form 4 |
- Oct 1510b5-1 planJoshua J. OfmanChief Executive Officer · sold 20,000 at avg $136.85$2.74M5.5% of stake
- Oct 5No planAndrew John PartridgeChief Growth Officer · sold 7,873 at $146.39$1.15M4.8% of stake
- Oct 5No planAaron FreidinChief Financial Officer · sold 23,619 at $146.39$3.46M9.5% of stake
- Sep 2110b5-1 planAaron FreidinChief Financial Officer · sold 4,100 at avg $93.34$383k1.6% of stake
- Sep 2110b5-1 planJoshua J. OfmanChief Executive Officer · sold 61,452 at avg $97.74$6.01M15% of stake
- Aug 2710b5-1 planJoshua J. OfmanChief Executive Officer · sold 5,000 at $85.02$425k1.2% of stake
- Aug 2710b5-1 planAaron FreidinChief Financial Officer · sold 7,900 at $85.01$672k3.0% of stake
- Jun 4No planAndrew John PartridgeChief Growth Officer · sold 1,491 at $61.08$91k0.9% of stake
- Apr 8No planAaron FreidinChief Financial Officer · sold 45,806 at $49.92$2.29M15% of stake
- Apr 8No planRobert P RagusaChief Executive Officer · sold 123,502 at $49.92$6.17M19% of stake
- Apr 8No planJoshua J. OfmanPresident · sold 61,665 at $49.92$3.08M14% of stake
- Mar 5 – 9No planAaron FreidinChief Financial Officer · sold 3,147 at avg $48.96$154k1.0% of stake
- Mar 5 – 9No planJoshua J. OfmanPresident · sold 3,627 at avg $48.86$177k0.8% of stake
- Mar 5 – 9No planRobert P RagusaChief Executive Officer · sold 8,441 at avg $48.48$409k1.3% of stake
- Mar 2No planJoshua J. OfmanPresident · sold 17,002 at avg $50.17$853k3.7% of stake
- Mar 2No planAaron FreidinChief Financial Officer · sold 9,573 at avg $50.17$480k3.0% of stake
- Mar 2No planRobert P RagusaChief Executive Officer · sold 37,504 at avg $50.17$1.88M5.5% of stake
- Dec 3, 2025No planJoshua J. OfmanPresident · sold 13,000 at $100.00$1.3M3.4% of stake
- Dec 3, 2025No planRobert P RagusaChief Executive Officer · sold 40,000 at avg $95.24$3.81M5.5% of stake
- Dec 3, 2025No planAaron FreidinChief Financial Officer · sold 25,000 at $99.15$2.48M8.8% of stake
- Nov 17, 2025No planAaron FreidinChief Financial Officer · sold 1,697 at $79.20$134k0.6% of stake
- Nov 17, 2025No planIllumina, Inc.Large holder · sold 1,000,000 at $79.85$79.8M22% of stake
- Oct 15, 2025 – Oct 16, 202510b5-1 planJoshua J. OfmanPresident · sold 14,979 at avg $78.47$1.18M3.8% of stake
- Oct 15, 2025No planRobert P RagusaChief Executive Officer · sold 7,239 at $68.88$499k1.0% of stake
- Oct 6, 2025No planJoshua J. OfmanPresident · sold 81,385 at $62.50$5.09M17% of stake
- Oct 2, 202510b5-1 planJoshua J. OfmanPresident · sold 9,692 at $64.00$620k2.0% of stake
- Aug 19, 2025No planJoshua J. OfmanPresident · sold 4,202 at $32.02$135k0.9% of stake
- Aug 19, 2025No planAaron FreidinChief Financial Officer · sold 877 at $32.02$28k0.3% of stake
- Jul 15, 202510b5-1 planAaron FreidinChief Financial Officer · sold 8,000 at $38.93$311k2.7% of stake
- Jul 1, 2025No planChun R DingLarge holder · sold 339,800 at avg $49.53$16.8M9.3% of stake
- Jun 30, 202510b5-1 planJoshua J. OfmanPresident · sold 9,692 at $52.00$504k1.9% of stake
- Jun 12, 202510b5-1 planJoshua J. OfmanPresident · sold 9,692 at $42.30$410k1.9% of stake
- May 2, 2025No planJoshua J. OfmanPresident · sold 48,213 at $33.93$1.64M8.6% of stake
- May 2, 2025No planAaron FreidinChief Financial Officer · sold 41,150 at $33.93$1.4M12% of stake
- May 2, 2025No planRobert P RagusaChief Executive Officer · sold 94,035 at $33.93$3.19M11% of stake
- Mar 11, 2025No planAaron FreidinChief Financial Officer · sold 1,816 at $31.20$57k0.5% of stake
- Mar 11, 2025No planRobert P RagusaChief Executive Officer · sold 7,625 at $31.21$238k0.9% of stake
- Mar 11, 2025No planJoshua J. OfmanPresident · sold 2,109 at $31.20$66k0.4% of stake
- Mar 7, 2025No planRobert P RagusaChief Executive Officer · sold 7,625 at $31.21$238k0.9% of stake
- Mar 7, 2025No planJoshua J. OfmanPresident · sold 2,109 at $31.20$66k0.4% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Services-Medical Laboratories
Spot a number that looks wrong? Check it in GRAL's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing GRAL
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.